Dmae as sole agent for the treatment of mild cognitive...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4015 (2006.01) A61K 31/133 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2667983

The present invention relates to the use, as sole active ingredient, of dimethylaminoethanol (DMAE) in free form or in the form of salts or of esters and also of hydrates and solvates thereof, for the manufacture of a medicament for use in the treatment of a non-dementia mild cognitive impairment characterized by an amnestic syndrome of hippocampal type.

La présente invention concerne l'utilisation à titre de principe actif unique de diméthylaminoéthanol (DMAE) sous forme libre, de sels ou d'esters ainsi que de leurs hydrates et solvates, pour la fabrication d'un médicament destiné au traitement d'un déficit cognitif léger non démentiel caractérisé par un syndrome amnésique de type hippocampique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dmae as sole agent for the treatment of mild cognitive... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dmae as sole agent for the treatment of mild cognitive..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dmae as sole agent for the treatment of mild cognitive... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1937799

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.